Table 3.
Meta-regression between changes in glycemic indices and administered doses and intervention duration of melatonin
| Regression | Dose-Response | |||||||
|---|---|---|---|---|---|---|---|---|
| Dose (mg/d) | Duration (week) | Dose (mg/d) | Duration (week) | |||||
| Variables | Coefficient | p-value | Coefficient | p-value | Coefficient | p-value | Coefficient | p-value |
| FBS (mg/dl) | −0.02 | 0.851 | 0.12 | 0.540 | 24.90 | 0.648 | −2.60 | 0.641 |
| Insulin (µIU/ml) | −0.58 | 0.034 | 0.13 | 0.697 | 618.37 | 0.001 | 11.06 | < 0.001 |
| HbA1c (%) | −0.82 | 0.786 | 13.09 | 0.314 | 5.94 | 0.503 | 0.52 | 0.338 |
| HOMA-IR | −1.40 | 0.120 | 1.80 | 0.492 | 0.03 | 0.003 | 0.96 | 0.304 |